Search

everythinglearnresearchcommunity

for

Search:↓

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Cocaine possibly mixed with levamisole caused a woman's skin condition and blood issues, which improved with treatment.

Finasteride may help reduce COVID-19 infection by altering a key gene.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Lamivudine might reverse hair graying and needs more research for potential treatments.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

GI197111X is best dissolved in Capmul MCM for trials.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.